Beyond direct effects on alcohol consumption, GLP-1 RAs benefit obesity and type 2 diabetes; collectively improving outcomes for those whose liver disease has both metabolic and alcohol-related causes (MetALD).17 This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.